CLOROX CO /DE/ — Director's Dealing 2024

Jan 22, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2024-01-11

Reporting Person: Hyder Chris T (Group President - Health & Hyg)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10831.0000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$123.0900	2026-09-13	Common Stock (1178.0000)		Direct
Stock Option (Right to Buy)	$127.6200	2032-03-14	Common Stock (2907.0000)		Direct
Stock Option (Right to Buy)	$135.5700	2027-09-12	Common Stock (3910.0000)		Direct
Stock Option (Right to Buy)	$141.3000	2032-09-20	Common Stock (8160.0000)		Direct
Stock Option (Right to Buy)	$151.8500	2028-09-18	Common Stock (4480.0000)		Direct
Stock Option (Right to Buy)	$155.5400	2029-09-17	Common Stock (8742.0000)		Direct
Stock Option (Right to Buy)	$163.7700	2031-09-21	Common Stock (5387.0000)		Direct
Stock Option (Right to Buy)	$212.3800	2030-09-22	Common Stock (3635.0000)		Direct

Footnotes

F1: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.

F2: Option vests in 4 equal installments - 1/4 on each of October 5, 2023, 2024, 2025 and 2026.

F3: Option vests in 4 equal installments - 1/4 on each of the first, second and third anniversaries of the grant date and 1/4 on September 13, 2022.

F4: Option vests in 4 equal installments - 1/4 on each of the first and second anniversaries of the grant date and 1/4 on each of September 13, 2022 and 2023.

F5: Option vests in 4 equal installments - 1/4 on each of October 5, 2022, 2023, 2024, and 2025.

F6: Option vests in 4 equal installments - 1/4 on the first anniversary of the grant date and 1/4 on each of September 13, 2022, 2023, and 2024.